TUESDAY, Oct. 1, 2024 (HealthDay News) — Clinical trials sponsored by Big Pharma enrolled eight times as many patients as U.S.-government trials did between 2018 and 2022, new research shows. The study — conducted by researchers at Fred Hutch Cancer Center in Seattle — underscores the lack of investment inContinue Reading
MONDAY, Sept. 30, 2024 (HealthDay News) — A shorter course of post-mastectomy radiation doesn’t jeopardize a patient’s chances of successful breast reconstruction, a new study finds. About 40 percent of people with breast cancer have mastectomies, followed by five to six weeks of radiation therapy to kill any cancer cellsContinue Reading
-690x550.jpg)
SATURDAY, Sept. 28, 2024 (HealthDay News) — Blood cancer is not a diagnosis anyone wants to receive, but understanding the different types of this disease and how best to catch them early is essential, one expert says. First, blood cancers are far more common than you might think: One personContinue Reading
THURSDAY, Sept. 26, 2024 (HealthDay News) — Bacteria that causes gum disease can also raise a person’s risk of head and neck cancers, a new study says. More than a dozen bacterial species have been linked to a collective 50% increased risk of head and neck cancer, researchers found. “OurContinue Reading
THURSDAY, Sept. 26, 2024 (HealthDay News) — There’s good news for folks who struggle to fit regular exercise into their busy workweek. “Weekend warrior” workouts are just as beneficial as daily exercise to a person’s overall health, a new study says. People who get all their weekly recommended exercise inContinue Reading
TUESDAY, Sept. 24, 2024 (HealthDay News) — Food sold in shrink wrap, on cardboard trays or in paper containers might contain any of nearly 200 chemicals linked to breast cancer, a new study warns. Commonly used food packaging materials contain 189 chemicals that can potentially cause breast cancer, researchers reportedContinue Reading
WEDNESDAY, Sept. 18, 2024 (HealthDay News) — Women with early stage breast cancer may now take Kisquali, a medication already approved for advanced disease, following the U.S. Food and Drug Administration’s expanded approval of the treatment, drug maker Novartis announced Tuesday. “The FDA approval of Kisqali for this early breastContinue Reading
WEDNESDAY, Sept. 18, 2024 (HealthDay News) — Black women have a higher risk of dying from any type of breast cancer than white women, a new review finds. Overall, the increased survival risk for Black women ranges from 17% to 50%, depending on the type of breast cancer, researchers found.Continue Reading
TUESDAY, Sept. 17, 2024 (HealthDay News) — Counties and states where jails and prisons are packed are more likely to have higher rates of cancer, new research shows. “These results aren’t surprising. Incarceration in the U.S. is recognized as a key element of social determinants of health and is linkedContinue Reading
TUESDAY, Sept. 17, 2024 (HealthDay News) — A small clinical trial suggests that a duo of drugs can extend survival for people battling advanced kidney cancer. Researchers at Roswell Park Comprehensive Cancer Center in Buffalo, N.Y., developed the new regimen, a combination of pazopanib (Votrient) and bevacizumab (Avastin). Pazopanib is fromContinue Reading